Independent Observers Report of the XXIII Olympic Winter Games Pyeongchang 2018 / McDevitt, Ben. - Independent Observer Team. - Montreal : World Anti-Doping Agency (WADA), 2018
Used filter(s): 158 items found
- Remove all filters
- Search all: meldonium
WADA - 2022 Anti-Doping Testing Figures Report
2022 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2024
Contents:
- Executive Summary - pp. 2-9 (7 pages)
- Laboratory Report - pp. 10-39 (30 pages)
- Sport Report - pp. 40-155 (116 pages)
- Testing Authority Report - pp. 156-279 (124 pages)
- ABP Report-Blood Analysis - pp. 280-320 (41 pages)
Report Highlights:
-
A 6.4% increase in the total number of samples (including urine, non-ABP blood and dried blood spot samples) analyzed and reported into ADAMS in 2022 (256,770) vs. 2021 (241,430);
-
An increase in the total percentage of AAFs year on year;
-
An increase in the total number of samples analyzed and reported by most WADA-accredited laboratories and WADA-approved laboratories into ADAMS in 2022 vs 2021.
-
An increase in the total number and percentage of non-ABP blood and DBS samples analyzed in 2022.
-
An increase of 1.4% in the number of ABP blood samples analyzed in 2022.
-
An increase in the total number of AAFs and % AAF for ERAs [including erythropoietin (EPO) and other EPO-receptor agonists], GHRFs and GC/C/IRMS tests in 2022.
The World Anti-Doping Agency (WADA) has published its 2022 Testing Figures Report (2022 Report), which summarizes the results of all the samples WADA-accredited laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2022.
The 2022 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples, blood and ABP blood data, and the resulting Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs).
WADA - 2021 Anti-Doping Testing Figures Report
2021 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2023
Contents:
- Executive Summary - pp. 2-9 (7 pages)
- Laboratory Report -– pp. 10-39 (30 pages)
- Sport Report - pp. 40-153 (114 pages)
- Testing Authority Report - pp. 154-267 (114 pages)
- ABP Report-Blood Analysis - pp. 268-311 (44 pages)
Report Highlights:
- A 61.2% increase in the number of samples (both urine and non-ABP blood samples) analyzed
and reported into ADAMS: 149,758 in 2020 to 241,430 in 2021. - An increase in the total number of samples analyzed and reported by nearly all WADAaccredited
laboratories and WADA-approved laboratories into ADAMS in 2021 compared to 2020. - An increase in the total number and percentage of non-ABP blood samples analyzed: 7.3%
(10,940 of 149,758 samples) in 2020 to 9.3% (22,398 Blood + DBS samples out of 241,430). - An increase of 36% in the number of ABP blood samples analyzed: 22,666 in 2020 to 30,821
in 2021. - A decrease in the total percentage of AAFs: 0.67% in 2020 (1,009 AAFs from 149,758
samples) to 0.65% (1,560 AAFs from 241,430 samples). - An increase in the total number of AAFs for growth hormone (GH): 1 in 2020 to 7 in 2021,
including the first reported AAF for a GH biomarker. - A 46% decrease in the overall number of samples analyzed: 278,047 in 2019 to 149,758 in 2020.
- A decrease in the total percentage of Adverse Analytical Findings (AAFs): 0.97% in 2019 (2,702 AAFs from 278,047 samples) to 0.67% in 2020 (1,009 AAFs from 149,758 samples).
- All WADA-accredited Laboratories saw a decrease in the total number of samples recorded.
- A decrease in the total number and percentage of non-Athlete Biological Passport (ABP) blood samples analyzed: 9.1% in 2019 (25,339 of 278,047) and 7.3% (10,940 of 149,758) in 2020.
- A decrease of 38% in the number of ABP blood samples tested: 36,401 in 2019 to 22,666 in 2020.
The World Anti-Doping Agency (WADA) has publishes its 2021 Testing Figures Report (2021 Report), which summarizes the results of all the samples WADA-accredited laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2021.
This is the first set of global testing figures under the 2021 World Anti-Doping Code (Code) that came into effect in January 2021. The 2021 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples, blood and ABP blood data, and the resulting Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs).
WADA - 2020 Anti-Doping Testing Figures Report
2020 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2021
Contents:
- Executive Summary - pp. 2-9 (7 pages)
- Laboratory Report -– pp. 10-36 (27 pages)
- Sport Report - pp. 37-137 (101 pages)
- Testing Authority Report - pp. 138-244 (107 pages)
- ABP Report-Blood Analysis - pp. 245-279 (35 pages)
Report Highlights:
- A 46% decrease in the overall number of samples analyzed: 278,047 in 2019 to 149,758 in 2020.
- A decrease in the total percentage of Adverse Analytical Findings (AAFs): 0.97% in 2019 (2,702 AAFs from 278,047 samples) to 0.67% in 2020 (1,009 AAFs from 149,758 samples).
- All WADA-accredited Laboratories saw a decrease in the total number of samples recorded.
- A decrease in the total number and percentage of non-Athlete Biological Passport (ABP) blood samples analyzed: 9.1% in 2019 (25,339 of 278,047) and 7.3% (10,940 of 149,758) in 2020.
- A decrease of 38% in the number of ABP blood samples tested: 36,401 in 2019 to 22,666 in 2020.
The World Anti-Doping Agency (WADA) has publishes its 2020 Testing Figures Report (2020 Report), which summarizes the results of all the samples WADA-accredited Laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2020.
This is the sixth and last set of global testing figures under the 2015 World Anti-Doping Code (Code) that came into effect in January 2015. The 2020 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples; blood and ABP blood data; and, the resulting Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs).
WADA - 2019 Anti-Doping Testing Figures Report
2019 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2020
Contents:
- Executive Summary - pp. 2-8 (7 pages)
- Laboratory Report -– pp. 9-37 (28 pages)
- Sport Report - pp. 38-174 (137 pages)
- Testing Authority Report - pp. 175-313 (139 pages)
- ABP Report-Blood Analysis - pp. 314-355 (42 pages)
Report Highlights
- A 5.5% increase in the overall number of samples analyzed: 263,519 in 2018 to 278,047 in 2019.
- A slight decrease in the total percentage of Adverse Analytical Findings (AAFs): 1.05% in 2018 (2,774 AAFs from 263,519 samples) to 0.97% in 2019 (2,702 AAFs from 278,047 samples).
- About 60% of WADA-accredited Laboratories saw an increase in the total number of samples recorded.
- An almost similar total number and percentage of non-Athlete Biological Passport (ABP) blood samples analyzed: 9.3% in 2018 (24,495 of 263,519) and 9.1% in 2019 (25,339 of 278,047).
- An increase of 16% in the number of ABP blood samples tested: 31,265 in 2018 to 36,401 in 2019.
- An increase in AAFs reported for Erythropoiesis Stimulating Agents (ESAs), Growth Hormone (GH) and Growth Hormone Releasing Factors (GHRFs).
The World Anti-Doping Agency (WADA) has published its 2019 Testing Figures Report (2019 Report), which summarizes the results of all the samples WADA-accredited Laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2019.
This is the fifth set of global testing figures under the version of the World Anti-Doping Code (Code) that came into effect in January 2015. The 2019 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples; blood and ABP blood data; and, the resulting AAFs and Atypical Findings (ATFs).
WADA - 2018 Anti-Doping Testing Figures Report
2018 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2019
Contents:
- Executive Summary - pp. 2-6 (5 pages)
- Laboratory Report -– pp. 7-34 (28 pages)
- Sport Report - pp. 35-159 (125 pages)
- Testing Authority Report - pp. 160-304 (145 pages)
- ABP Report-Blood Analysis - pp. 305-343 (39 pages)
WADA - 2017 Anti-Doping Testing Figures Report
2017 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2018
Contents:
- Executive Summary - pp. 2-9 (7 pages)
- Laboratory Report -– pp. 10-36 (26 pages)
- Sport Report - pp. 37-158 (121 pages)
- Testing Authority Report - pp. 159-298 (139 pages)
- ABP Report-Blood Analysis - pp. 299-336 (37 pages)
WADA - 2016 Anti-Doping Testing Figures Report
2016 Anti-Doping Testing Figures Report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2017
Contents:
- Executive Summary - pp. 2-9 (7 pages)
- Laboratory Report -– pp. 10-36 (26 pages)
- Sport Report - pp. 37-150 (113 pages)
- Testing Authority Report - pp. 151-287 (136 pages)
- ABP Report-Blood Analysis - pp. 288-323 (35 pages)